You are on page 1of 4

DAFTAR PUSTAKA

1.

Jack MG, Luigi. Demography and Epidemiology. In: Hazzard Geriatric


Medicine and Gerontology. 6, editor: Halter JB, Joseph GO, Mary ET,
Stephanie S, Kevin PH. New york: McGraw Hill Medical; 2009. p. 45.

2.

Kementerian kesehatan RI. Populasi Lansia Diperkirakan Terus Meningkat


Hingga Tahun 2020. Jakarta: Kementerian kesehatan RI ; 9 Oktober 2013
[cited 2014 30 Juni]; Available from: http://www.depkes.go.id/index.php?
vw=2&id=SNR.13110002.

3.

Census US. Mid-year Population by Older Age Groups and Sex-Custom


Region-Indonesia. International Data Base; 2014 [cited 2014 1 Juli];
Available from: www.census.gov/population/international/data/idb/region.

4.

Nolte MS, Karam JH. Obat Kardiovaskular. In: Katzung Bertram.


Farmakologi Dasar dan Klinik. 10 ed. Jakarta: EGC; 2010. p. 353-358.

5.

Sriwijaya S. Farmakologi Dasar dan Klinik. Jakarta: EGC; 2009. Available


from: http://books.google.co.id/books.dosis+geriatri. p.379.

6.

Suardi HN. Survei ketepatan penggunaan obat kardiovaskular pada pasien


usia lanjut di Ruang Rawat Inap Penyakit Dalam RSCM/FKUI. Center for
Research and Integrated Development of Tropical Health and Infectious
Diseases.2010.
[cited
2014
14
Agustus];
Availablefrom:http://perpustakaan.fk.ui.ac.id:8080/opac/themes/new/listti
pekoleksi.jsp?id=3&start=40&lokasi=lokal&prefix=S .p.ii.

7.

Coliseum Health System. Cardiovascular Disease: Reducing Your Risk


EBSCO;
2014
[cited
2014
18
Juli];
Available
from:
http://coliseumhealthsystem.com/yourhealth/2010811483/Cardiovascular-Disease--Reducing-Your-Risk. p. 38.

8.

Sherwood L. Fisiologi Manusia. 2 ed. Jakarta: EGC; 2001. p. 837.

9.

Aaronson PI, Jeremy PTW. At a Glance Sistem Kardiovaskular. Jakarta


Erlangga; 2010. p. 10-11.

10.

Corwin EJ. Buku Saku Patofisiologi Jakarta: EGC; 2009. Available


from:http://books.google.co.id/books?
id=0bMJ2p9GdAC&printsec=frontcover#v=onepage&q&f=false. p. 441.
11. Smith K, Daniel MR, Nickole H. Clinical Drug Data. New York:
mcgraw-hill; 2010. [cited 2014 16 Juni ];Available from:http://mcgrawhill.co.uk/openup/chapters/9780335243976.pdf. p. 5-19.

30

31

12.

Delima LM, Hadi S. Prevalensi dan Faktor Determinan Penyakit Jantung


di Indonesia. Ejournal Litbang ; 2009.[cited 2014 5 Juli]; Available from:
http://ejournal.litbang.depkes.go.id/. p. 86-87.

13.

Gray HH, Keith DD, John MM, Ian AS. Lecture Notes Kardiologi Jakarta:
Erlangga; 2003. [ cited 2014 5 Juli ]Available from:
http://books.google.co.id/books?
id=VbLekHPo5CEC&pg=PA8&dq=sistem+kardiovaskular. p. 8-10.

14.

Longmore M, Ian W, Tom T, Chee KC. Oxford Handbook of Clinical


Medicine. Inggris: Oxford University Press; 2007. [cited 2014 10 Juli]
Available
from:
http://medicalbay.blogspot.com/2013/03/oxfordhandbook-of-clinical-medicine.html. p. 4-5.

15.

Porter RS, Justin LK, Albert MA , Glenn DB ,Sidney C ,Linda E, et al.


The Merck Manual of Diagnosis & Therapy. United States: Planet
Friendly Publishing; 2011. [cited 2014 6 Juli] Available from:
http://www.4shared.com/office/07jSGY0/the_merck_manual_of_diagnosis
_.htm. p. 2044.

16.

WHO. Definition of an older or elderly person. United States: WHO; 2011 [cited
2014
21
September];
Available
from:
http://www.who.int/healthinfo/survey/ageingdefnolder/en/

17.

Markum H. Anamnesis dan Pemeriksaan Fisis. Jakarta Fakultas


Kedokteran Universitas Indonesia; 2000. p. 16-20.

18.

Setiati S, Kuntjoro H, Arya GRS. Proses Menua dan Implikasi Kliniknya.


In: Ilmu Penyakit Dalam Jakarta: Departemen Ilmu Penyakit Dalam
Fakultas Kedokteran Universitas Indonesia 2006. p. 1345-1348.

19.

Martono H. Buku Ajar Geriatri 4ed. Jakarta: FKUI; 2011. p. 45-50.

20.

Alberto CA, Beatrice D, Epietro AM, Carlo N. New evidence in


cardiovascular and geriatric medicine. Spinger. 2008. [cited 2014 18 Juli]
Available from: http://link.springer.com/article/10.1007%2Fs11739-0080162-y. p.1-2.

21.

Aronow WS, William HF, Angela CL. Cardiovascular Drug Therapy in the
Elderly. spinger. 2007;15. [cited 2014 18 Juli] Available from:
http://epartamentos.cardiol.br/DECAGE/esquina/superligado/Cardiovasc
ular_Drug_Therapy_in_the_Elderly.pdf. p.195.

22.

Dalane WK, George T. Effecs of Aging on Cardiovascular Structure and


Function . In: Hazzard Geriatric Medicine and Gerontology. 6, editor.
New york: McGraw Hill Medical; 2009. p. 883.

32

23.

Ganiswarna GS, Frans DSP, Nafrialdi. Farmakologi dan Terapi. 4 ed.


Jakarta: Bagian Farmakologi Fakultas Kedokteran Universitas Indonesia;
2004. p.552.

24.

Cohen L, Lawrence D, Jonathan I, Forrester AL, Craig AM, Marvin M, et


al.Cardiovascular Drug. United States: Yale University School Of
Medicine; 2004. [cited 2014 15 Juli] Available from: www.med.yale.edu. p.
287-301.

25.

Gabriel KM. Cardiac Drug Therapy. New Jersey: Humana Press; 2007.
[cited 2014 15 Juli] Available from: http://elib.fk.uwks.ac.id/asset/archieve/ebook/CARDIOLOGI%20AND%20CARDIOVASCULAR%20%20JANTUNG
%20%20PEMBULUH%20DARAH/CARDIAC%20DRUG%20THERAPY.pdf.

p.1-189.
26.

Semla TP, Judith L.B, Martin D.H. Geriatric Dosage Hanbook. 6 ed. New
York: American Pharmaceutical Association; 2001. p. 91-735.

27.

Cowie M. R, Philip W. D. Pathophysiology of Heart Failure. New York:


Springer;
2013.[cited
2014
5
Juli]
Available
from:
http://link.springer.com/chapter/10.1007/978-1-4614-6705-2_18. p. 327345.

28.

Mansoor AH , Upendra K. Beta-blockers in Cardiovascular Medicine.


JAPI. 2009;57. [cited 2014 8 Juli];
Available from:
http://www.japi.org/special_issue_2009/article_02.html. p. 1-9.

29.

Pharmacology and Therapeutics Committee. Angiontensin Converting


Enzyme Inhibitor (ACE Inhibitor). Mcgill University Health Centre .
2001.
[cited
2014
8
Juli]
Available
from:
http://www.pharmactuel.com/annexes/200304ge/Annexe1.pdf. p. 7-10.

30.

Elliott JW, Venkata SR. Calcium Channel Blockers. ASH 2011;19(9).


[cited
2014
19
Juli]
Available
from:
http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2011.00513.x/pdf.
p. 687-689.

31.

Syamsuni. Farmasetika Dasar dan Hitungan Farmasi. Jakarta: ECG; 2006


[cited 2014 29 Agustus] Available from: http://books.google.co.id/books?
id=rLWvvfL8BcC&printsec=frontcover#v=onepage&q&f=false. p.18.
Rubenstein D WD, Bradley J. Kedokteran Klinis. Jakarta: Erlangga; 2003.
[cited 2014 28 Agustus] Available from: http://books.google.co.id/books?
id=lhDl8_eIsiEC&pg=PA229&dq=klirens+kreatinin+merupakan&hl=en
&sa=X&ei=OHH_U4UIJeIuASWiILYBA&ved=0CBoQ6AEwAA#v=onep
age&q=klirens%20kreatinin%20merupakan&f=false. p. 10.

32.

33

33.

34.

38.

Rachman F, Berbagai Faktor yang berhubungan dengan kejadian


hipertensi pada Lansia di rumah sakit Dr Kariadi Semarang. Skripsi.2011;
p.14

Oparil, Suzanne, Tonons NS, J.Findaly W. Role of angiotensin receptor blockers


as monotherapy in reaching blood pressure goals. AMJ hypertension. 2004 July;
18(2). p. 287-294
35.

G Mendelson, Ness J, WS Aronow. Drug Treatment of hypertension in


older persons in an academic hospital-based geriatrics practice. Journal of
the American Geriatric Society. 2006;47(5): p. 15

36.

Kutner M, Glenford, Felix S. Physician Attitude Toward oral


Anticoagulant and Antiplatelet Agent for stroke Prevention in Elderly
Patient with Artial Fibrillation. Jama Internal Medicine.2000;151(10):p.5
[cited
2014
17
Desember]
Available
from:
http://archinte.jamanetwork.com/

37.

Quilliam BJ, Kate LP, Charles BA, Vincent M. Effect of Antiplatelet and
anticoagulant Agent on Risk of Hospitalization for Bleeding Among a
population of Elderly Nursing Home Stroke Survivors. AHA. 2001; p. 2
[cited
2014
17
Desember]
Available
from:
2001.
http://stroke.ahajournals.org/

Vanpee D, Swinee.Elderly heart failure patients with drug-induced serious


hyperkalemia. Spinger link. 2014; p. 23 [cited 2014 17 Desember] Available
from: http://link.springer.com/article/10.1007/BF03339853